A rep's plain-English guide to how devices reach market: the FDA risk classes, the 510(k) clearance vs. PMA approval pathways, where De Novo fits, and why it matters in front of customers.
The short version
- The FDA classifies devices by risk: Class I (low), Class II (moderate, usually 510(k)), and Class III (high, usually PMA).
- A 510(k) clears a device by showing substantial equivalence to an existing predicate; the device is cleared, not approved.
- A PMA is the most rigorous pathway for high-risk devices and requires clinical data; the device is FDA approved.
- De Novo is a route for novel low-to-moderate-risk devices with no predicate, and often signals a genuinely new product.
- Reps should know their product's pathway, use cleared vs. approved accurately, and understand the evidence behind it.
Reps are not regulatory specialists, and no customer expects you to be. But every device you sell reached the market through an FDA pathway, and that pathway shapes what you can claim, what evidence you have, and how a clinically-minded customer will size up your product. Understanding the basics makes you more credible and keeps you out of trouble.
Here is the plain-English version of how medical devices get to market in the US, and why it matters when you are the one in the room.
01How does the FDA classify medical devices?
By risk, into three classes. Class I devices are low-risk, think bandages and exam gloves, and most are exempt from premarket review. Class II devices are moderate-risk, a large middle that includes many of the devices reps sell, from infusion pumps to many surgical instruments, and they generally reach the market through the 510(k) pathway. Class III devices are the highest-risk, life-sustaining or implantable devices where a failure could be serious, and they generally require the more rigorous PMA pathway.
The class is not a marketing label; it is a statement about risk and the level of evidence the FDA required. Knowing which class your product is in tells you, roughly, how heavy the clinical bar was to get it cleared or approved, which is exactly the context a physician is thinking in.
02What is the 510(k) pathway?
The 510(k) is a premarket submission that clears a device by showing it is substantially equivalent to a device already legally on the market, called a predicate. It is the pathway most Class II devices take. Rather than proving safety and effectiveness from scratch, the manufacturer demonstrates the new device is as safe and effective as one that already exists.
For a rep, the practical meaning is that a 510(k) device is cleared, not approved, and its case often rests on equivalence and bench or limited clinical data rather than large trials. That is completely normal and appropriate for its risk level, but be precise with language: a 510(k) device has FDA clearance, and claiming FDA approval for it is both inaccurate and a compliance problem.
03What is the PMA pathway?
Premarket Approval, or PMA, is the FDA's most stringent pathway, reserved for the highest-risk Class III devices. It requires the manufacturer to independently demonstrate safety and effectiveness, typically through significant clinical trial data, so it is a longer, more expensive, and more rigorous process than a 510(k).
A PMA device is FDA approved, and that approval is a real selling point, because it signals a high evidentiary bar and a body of clinical data behind the product. When you sell an approved device, you usually have meaningful clinical evidence to speak to, and understanding that evidence is a core part of selling it credibly to a data-driven customer.
04Where does De Novo fit?
The De Novo pathway is for novel low-to-moderate-risk devices that have no existing predicate to compare to, so a 510(k) does not fit, but the risk does not warrant a full PMA. It provides a route to market for genuinely new device types and, once granted, can serve as the predicate for future 510(k) submissions.
You will encounter De Novo most with innovative products in emerging categories. The useful takeaway for a rep is simply that not every device fits neatly into 510(k) or PMA, and a De Novo product is often a sign you are selling something genuinely new, which changes how you tell its story.
05Why does any of this matter to a rep?
Three reasons. Credibility: a clinically-minded customer respects a rep who understands how their product got to market and what evidence stands behind it. Accuracy: using cleared versus approved correctly, and never overstating a device's regulatory status, keeps you honest and compliant, which matters enormously in healthcare. And evidence: the pathway tells you what data you have to sell with, and knowing that data cold is what wins a data-driven physician.
You do not need to memorize regulations. You need to know your own product's pathway, speak about it accurately, and understand the clinical evidence behind it. That basic fluency separates a rep who sounds like a professional from one who sounds like they are just reading the brochure.
Frequently Asked Questions
What is the difference between 510(k) and PMA?
A 510(k) clears a moderate-risk device by showing it is substantially equivalent to a device already on the market, so it is cleared, not approved. A PMA is the FDA's most rigorous pathway for high-risk Class III devices and requires independent clinical evidence of safety and effectiveness, resulting in FDA approval.
Is a 510(k) device FDA approved?
No, it is FDA cleared, not approved. Clearance through the 510(k) pathway means the device was shown to be substantially equivalent to an existing legally marketed device. Only devices that go through the PMA pathway are FDA approved, and using the terms correctly matters for compliance.
Why do medical sales reps need to understand FDA pathways?
Because the pathway shapes the product's evidence, claims, and credibility. Understanding whether your device was cleared or approved, and what data stands behind it, makes you credible with clinical customers, keeps your language accurate and compliant, and tells you what evidence you have to sell with.
What are the FDA medical device classes?
Class I is low-risk and mostly exempt from premarket review, Class II is moderate-risk and usually reaches market via the 510(k) pathway, and Class III is high-risk, life-sustaining or implantable, usually requiring the PMA pathway. The class reflects risk and the evidence the FDA required.
About This Series
This piece is part of The Lobby’s series on how the medical sales business actually works, built from practitioner accounts and the reps who do it well.
Getting fluent in the industry? Set your parameters once on The Lobby and let matching roles come to you.